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Intratesticular cellular angiofibroma — a rare benign tumour:  
case report and literature review
Tomasz Piecha1, Agnieszka Powała2, Bolesław Kuzaka1
Cellular angiofibroma is a rare and benign tumour of mesenchymal origin. Within a microscopic image, two main cell 
populations are typically observed: spindle-shaped cells and blood vessels; both of which are sometimes accompa-
nied by atypical liposarcoma-like cells. 
We present a case of a 31-year old male admitted to the Department of Urology because of a solid mass being present 
in the left testis. The patient underwent radical orchidectomy through the inguinal canal. Microscopic examination 
demonstrated an intratesticular cellular angiofibroma. During a two-year follow-up, there were no signs observed 
of any metastases nor disease recurrence. 
Intratesticular localisation of cellular angiofibroma has never been previously reported. Benign tumours of the testis 
are rare, but an awareness of this phenomenon may reduce the number of unnecessary orchidectomies, thereby 
increasing the rate of organ-sparing surgery.
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Introduction
Cellular angiofibroma, also known as an angiomyofi-
broblastoma-like tumour, is a rare and benign tumour that 
was first described in 1997 by Nucci et al. [1]. By and large 
under microscopic investigation, the tumour consists of two 
main elements: spindle-shaped cells and blood vessels that 
are distributed in a chaotic manner [1, 2]. The original study 
concerned four cases of a vulva tumour in middle-aged wo-
men. This neoplasm was also subsequently described in ma-
les [2]. Cellular angiofibroma has been previously identified 
at different localisations, however to date, there has been 
no evidence of any authentic intratesticular development.
This study reports a case of a benign intratesticular tu-
mour with the pathological characteristics of cellular an-
giofibroma.
Case report
A thirty-one year old man was admitted to the Urology 
Department because a solid mass had been found in the 
left testis. This lesion had been detected incidentally during 
scrotal ultrasonography which was performed during the 
diagnosis of epididymitis. Ultrasound examination revealed 
a solid mass with dimensions of 12 × 11 × 8 mm in the 
lower-lateral region of the left testicle (Fig. 1). The lesion 
was situated intratesticularly, approximately 2 mm from the 
tunica albuginea. In the Colour Doppler image presenta-
tion, an intense blood flow was detected inside the tumour 
(Fig. 2). On physical examination, a palpable tumour was not 
present. Laboratory tests showed a minor increased level of 
alpha-fetoprotein to 9 ng/mL (normal range 0–7 ng/mL). 
Other laboratory tests, including testicular cancer markers 
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(i.e. beta-human chorionic gonadotropin and lactate de-
hydrogenase), were within reference ranges. Upon chest 
X-ray, metastatic lesions were not detected. The patient 
was qualified for a left radical orchidectomy through the 
inguinal canal. Intraoperatively, no macroscopic lesions in 
the left testis were observed.
Pathological examination revealed a gray-brown intra-
testicular tumour, size 12 × 10 × 8 mm, which was situated 
5 mm from the tunica albuginea. Microscopic investigation 
found spindle-shaped cells, abundant blood vessels and 
reactive changes. These features were consistent with the 
characteristics of cellular angiofibroma (Figs. 3–5). 
The postoperative course was without any complica-
tions. During the two-year follow-up, no signs of recurrence 
nor metastasis were observed 
Discussion
The vast majority of testicular neoplasms are germ cell 
tumours, which account for approximately 90–95% of re-
ported cases. Intratesticular tumours are seldom of mesen-
chymal origin, which constitute up to 2–4% of neoplasms; 
most of these being Leydig cell and Sertoli cell lesions [3]. 
Epidemiological data clearly demonstrates that the majority 
of intratesticular masses represent malignant neoplasms. 
Figure 1. Ultrasound image of a hypoechoic mass, 12 × 11 × 8 mm, in the lower lateral region of the left testicle
Figure 2. Color Doppler image presentation of testicular mass. Strongly increased blood flow observed inside lesion
273
Figure 3. Intratesticular Cellular Angiofibroma microscopic image at mag. × 40. Hemtoxilin-eosin staining. At low magnification, multiple cells and 
small blood vessels with a uniform distribution are visible
Figure 4. Intratesticular Cellular Angiofibroma microscopic image at mag. × 100. Hematoxilin-eosin staining. A clear boundary between tumor 
tissue and testicular tissue is apparent. Significantly increased intratumor cellularity with characteristic spindle-shaped cells observed
Figure 5. Intratesticular Cellular Angiofibroma microscopic image at mag. × 200. Hematoxilin-eosin staining. Multiple spindle shaped cells with 
a uniform, pale cytoplasm are present. Abundant medium- and hyalinized thick-walled blood vessels observed
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This situation has resulted in establishing radical orchidec-
tomy, via the inguinal canal, as the treatment of choice 
for intratesticular tumours. Benign testicular tumours are 
extremely rare, compared to paratesticular lesions, where 
benign neoplasms commonly occur [4]. A major problem 
in preoperatively differentiating between benign and ma-
lignant tumours is a lack of reliable imaging studies; i.e. 
scrotal ultrasound examination, computed tomography or 
magnetic resonance imagining do not allow conclusions 
to be drawn about the biological nature of the tumour. 
Nevertheless, a routine scrotal ultrasound has considerable 
accuracy for confirming the presence of a pathological mass 
and can also specify the location of the tumour, especially 
in distinguishing between intratesticular and paratesticular 
localisations [4]. 
Cellular angiofibroma (CAF), also known as angiomy-
ofibroblastoma-like tumour, is a rare and benign neoplasm 
of mesenchymal origin. CAF is mainly found in patients 
aged over 40 years, which is typically localised in the vulva 
of women and in the scrotum and groin in men [5]. The 
published literature however describes several case reports 
of CAF found in unusual locations, such as the prostate or 
elbow [6, 7]. Other described locations are listed in Table I. 
Usually described neoplasms are encapsulated and situated 
in superficial tissues [8]. Cellular angiofibroma is microsco-
pically characterised by mesenchymal spindle-shaped cells, 
thick-walled blood vessels of small and medium diameter 
and intracellular substance. The total absence of any normal 
tissue architecture is noticeable [1, 5]. Some researchers 
suggest that CAF may be derived from perivascular stem 
cells, which normally differentiate into myofibroblasts or 
adipocytes [5, 9]. Genetic mutation has been described 
in CAF cells. Studies have observed deletion of the 13q14 
region, which encodes RB1 and FOXO1 genes. This may 
indicate a genetic similarity to spindle-cell lipomas and 
mammary-type fibroblastomas [10]. Atypical cells resem-
bling well-differentiated liposarcoma cells or pleomorphic 
liposarcoma cells occur quite frequently, which is observed 
in microscopic images of cellular angiofibroma. Nonethe-
less, the presence of such populations does not alter the 
course of treatment nor of the overall prognosis. Moreover, 
in no reported cases have there been any clinical features 
of malignancy or of poor outcome [9].
Cellular angiofibroma is a pathologically and clinical-
ly benign tumour, and the treatment of choice is surgical 
excision [9]. All of such described cases have a good clinical 
outcome; infiltration or metastatic changes have not been 
observed [8, 11]. Only a single study reporting local recur-
rence six months after CAF excision has been published [12]. 
The aim of this study is to thus spread knowledge on the 
occurrence of benign testicular tumours. It seems to us that 
through such awareness, it is possible to at least in part avoid 
unnecessary orchidectomies. In our opinion, for low risk 
cases where testicular cancer markers are within reference 
ranges, the use of intraoperative pathological examination 
may result in a wider application of organ-sparing surgery.
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